Walleye Trading LLC Paratek Pharmaceuticals, Inc. Transaction History

Walleye Trading LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$4.7 - $7.24 $63,793 - $98,268	-13,573 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$6.81 - $10.93 $92,432 - $148,352	13,573 New	13,573 $93,000
Q3 2019 Nov 14, 2019	SELL	$3.08 - $5.76 $116,661 - $218,171	-37,877 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$3.47 - $6.32 $131,433 - $239,382	37,877 New	37,877 $151,000
Q1 2019 May 15, 2019	SELL	$5.36 - $7.24 $61,720 - $83,368	-11,515 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$4.8 - $11.6 $30,312 - $73,254	6,315 Added 121.44%	11,515 $59,000
Q3 2018 Nov 14, 2018	BUY	$9.05 - $10.95 $47,060 - $56,939	5,200 New	5,200 $50,000

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.